Blue Crest Capital Management LTD Hutchmed (China) LTD Transaction History

Blue Crest Capital Management LTD

  • $1.71 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$17.17 - $25.95 $772,650 - $1.17 Million
-45,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$22.0 - $31.78 $990,000 - $1.43 Million
45,000 New
45,000 $990,000
Q4 2018

Feb 14, 2019
SELL
$23.09 - $37.69 $203,192 - $331,672
-8,800 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$26.55 - $34.38 $233,640 - $302,544
8,800 New
8,800 $283,000

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email